Health Law Alliance LLC (“HLA”) successfully secured the reversal of an OptumRx network termination involving an independent California pharmacy. The termination stemmed from disputed PBM audit findings that failed to accurately account for the pharmacy’s inventory records and supporting documentation.
Through a comprehensive factual and legal challenge, HLA demonstrated material deficiencies in OptumRx’s audit findings, prompting OptumRx to reconsider its determination, reevaluate the pharmacy’s evidence, and ultimately rescind its network termination notice.
Inaccurate OptumRx Audit Findings Lead to Network Termination
The pharmacy had previously undergone an OptumRx audit, following which OptumRx identified purported inventory shortages as well as other discrepancies and issued a substantial recoupment demand. OptumRx subsequently relied upon those same disputed findings as the basis for terminating the pharmacy’s network participation.
However, the audit findings were fundamentally flawed. OptumRx’s inventory reconciliation failed to properly account for the pharmacy’s complete inventory records and overlooked critical supporting documentation, including patient confirmations of receipt, dispensing records, and other evidence establishing that the prescriptions at issue had been properly dispensed.
Despite the pharmacy’s submission of this evidence, OptumRx proceeded with its adverse findings and ultimately issued a network termination notice, jeopardizing the pharmacy’s continued operations and ability to serve its patients.
HLA Challenges the Audit Findings and Secures Reversal
HLA’s PBM audit defense attorneys undertook a comprehensive review of the audit findings, underlying inventory calculations, supporting documentation, and applicable contractual and legal requirements.
Rather than simply contesting the termination, HLA challenged the very findings upon which OptumRx’s decision was based. HLA identified deficiencies in the inventory reconciliation, demonstrated that material evidence had not been properly considered, and presented a detailed factual and legal analysis challenging the basis for OptumRx’s adverse determination.
As a result of HLA’s advocacy, OptumRx reconsidered its decision, reevaluated the pharmacy’s evidence, and rescinded the termination notice, allowing the pharmacy to maintain its OptumRx network participation.
OptumRx Audit Findings and Network Terminations Can Be Challenged
This outcome demonstrates that PBM audit findings are not necessarily conclusive, particularly where they rely on incomplete inventory calculations, overlook supporting documentation, or fail to account for evidence contradicting alleged discrepancies.
For independent pharmacies, the consequences of an erroneous PBM determination can be severe. Recoupment demands and network terminations can threaten a pharmacy’s financial stability, disrupt patient care, and jeopardize its continued operations.
A termination notice, however, is not necessarily the final word. Careful examination of the underlying audit findings, combined with effective factual and legal advocacy, can be instrumental in challenging unsupported PBM determinations.
Experienced PBM Audit Defense Attorneys
HLA represents independent pharmacies nationwide in disputes involving OptumRx, CVS Caremark, Express Scripts, Prime Therapeutics, Humana and other major PBMs and insurance payors. Our PBM audit attorneys handle pharmacy audits, recoupment demands, credentialing denials, network terminations, and related regulatory disputes.
HLA’s successful reversal of this California pharmacy’s OptumRx termination underscores the importance of challenging inaccurate audit findings before they result in potentially devastating consequences for independent pharmacies.
Facing a PBM audit, recoupment demand, or pharmacy network termination? Contact Health Law Alliance to discuss your legal rights and options for challenging adverse PBM determinations.
